SyntekaBio Enters ‘Assetization Phase’ for AI Asset Program 송영두 2026.01.21 오전 09:27 Cellumed Hits Upper Limit on Hopes for Ownership Sale[K-Bio Pulse] 신민준 2026.01.20 오전 08:00 BL Pharmtech Hits Upper Limit on Expectations for Molecular Glue Technology License Out[K-bio pul... 신민준 2026.01.16 오전 08:00 Pharos iBio Surges...Orum Therapeutics Hits New High[K-Bio Pulse] 김새미 2026.01.06 오전 08:00 Samsung Biologics to Join 2026 J.P. Morgan Healthcare Conference 송영두 2026.01.04 오전 09:44 Rznomics·Gencurix, JPMHC Attendees Draw Attention[K-Bio Pulse] 나은경 2026.01.12 오전 08:10 Celltrion forecasts record Q4 results on strong profit growth 송영두 2025.12.31 오전 09:08 WSI Surges 16%...Cellumed Hits Limit Down [K-bio pulse] 김진수 2025.12.31 오전 08:00 Rznomics Extends IPO Rally...HansBiomed Slides on Going Concern Fears[K-Bio Pulse] 김새미 2025.12.22 오전 08:00 SyntekaBio Licenses Out Five AI-Designed Multispecific Antibodies to Panolos 송영두 2025.12.16 오후 04:33 더 보기 로딩중..